Sanofi
Holdings as of Sep 30, 2026 · filed Nov 5, 2026
| # | Holding | Value | % Port. | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Meiragtx Holdings Plc | $134175107 | 21.30% | — | Held |
| 2 | Inhibrx Biosciences, Inc. | $115885234 | 18.40% | — | Held |
| 3 | Novavax | $74378000 | 11.81% | — | Held |
| 4 | Korsana Biosciences | $63808352 | 10.13% | — | NEW BUY |
| 5 | Odyssey Therapeutics Inc. | $44222244 | 7.02% | -1718 | -0.09% |
| 6 | Anaptysbio | $41309548 | 6.56% | — | Held |
| 7 | Agomab Therapeutics Nv | $30892366 | 4.90% | — | Held |
| 8 | First Tracks Biotherapeutics Inc. | $29128738 | 4.62% | — | Held |
| 9 | Electra Therapeutics Inc | $27696915 | 4.40% | — | NEW BUY |
| 10 | Attovia Therapeutics Inc | $18560135 | 2.95% | — | NEW BUY |
| 11 | Latigo Biotherapeutics Inc | $11235393 | 1.78% | — | NEW BUY |
| 12 | Immuneering Corp | $11091549 | 1.76% | — | Held |
| 13 | Maplight Therapeutics Inc. | $9293698 | 1.48% | — | Held |
| 14 | Scribe Therapeutics | $9202500 | 1.46% | — | NEW BUY |
| 15 | Sab Biotherapeutics Inc | $6969245 | 1.11% | — | NEW BUY |
| 16 | Q32 Bio Inc. | $2018566 | 0.32% | — | Held |
Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.